General Information
Version
6.6
Revision date
2024-02-26
Product name
Risedronate sodium
CAS No.
329003-65-8
REACH No
is
Emergency telephone
800-789-767 (CHEMTREC Italia
Icons in SDS
Company Information
company name
Merck Life Science S.r.l
e-mail address of the competent person responsible for the Safety Data Sheet
serviziotecnico@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H319, H361, H371
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Acute toxicity, (Category 4) H302: Harmful if swallowed. Eye irritation, (Category 2) H319: Causes serious eye irritation. Reproductive toxicity, (Category H361: Suspected of damaging fertility or 2) the unborn child. Specific target organ toxicity - H371: May cause damage to organs. single exposure, (Category 2)
2.2 Label elements
Labelling
Signal word
Warning Warning
Hazard statements
H302 Harmful if swallowed. H319 Causes serious eye irritation. H361 Suspected of damaging fertility or the unborn child. H371 May cause damage to organs. Reduced Labeling (<= 125 ml) H361 Suspected of damaging fertility or the unborn child.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P301 + P312 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P311 IF exposed or concerned: Call a POISON CENTER/ doctor. P202 Do not handle until all safety precautions have been read and understood.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
